Finasteride + tamsulosin


Generic Medicine Info
Contraindications
Hypersensitivity, pregnancy, lactation. Women and children.
Special Precautions
Avoid exposure of pregnant women to finasteride, either via direct contact with crushed tab or through semen of male sexual partners who are on this drug. Undiagnosed prostate cancer, liver diseases. Prostate carcinoma should be ruled out before starting the therapy. Hepatic impairment.
Adverse Reactions
Gynecomastia, decreased libido, impotence, reduction in the volume of ejaculate, genital abnormalities in the male foetus of pregnant women exposed to finasteride. Hypersensitivity reactions such as swelling of lips and rashes, postural hypotension, dizziness and vertigo; headache, infection, asthenia, back pain, chest pain, dizziness, somnolence, insomnia, decreased libido, rhinitis, pharyngitis, cough, sinusitis, diarhoea, nausea, tooth disorder, amblyopia.
Drug Interactions
Caution when used with cimetidine or warfarin. Not to be used with other alpha-adrenergic blocking agents.
ATC Classification
D11AX10 - finasteride ; Belongs to the class of other dermatologicals.
G04CB01 - finasteride ; Belongs to the class of testosterone-5-alpha reductase inhibitors. Used in the treatment of benign prostatic hypertrophy.
G04CA02 - tamsulosin ; Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.
Disclaimer: This information is independently developed by CIMS based on finasteride + tamsulosin from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in